Fig. 1From: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institutiona. Clinical photographs of patient 4. b. PET imaging showing the site of progression of patient 4 before and after switching therapy to Nivolumab/Pembrolizumab. c. Clinical photographs of patient 6Back to article page